Enveric Biosciences Statistics
Total Valuation
ENVB has a market cap or net worth of $10.56 million. The enterprise value is $5.89 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ENVB has 1.99 million shares outstanding. The number of shares has increased by 698.70% in one year.
| Current Share Class | 1.99M |
| Shares Outstanding | 1.99M |
| Shares Change (YoY) | +698.70% |
| Shares Change (QoQ) | +110.60% |
| Owned by Insiders (%) | 2.00% |
| Owned by Institutions (%) | 8.26% |
| Float | 1.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.30 |
| P/TBV Ratio | 2.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.38
| Current Ratio | 5.38 |
| Quick Ratio | 5.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -82,777.81 |
Financial Efficiency
Return on equity (ROE) is -304.04% and return on invested capital (ROIC) is -190.08%.
| Return on Equity (ROE) | -304.04% |
| Return on Assets (ROA) | -134.11% |
| Return on Invested Capital (ROIC) | -190.08% |
| Return on Capital Employed (ROCE) | -210.04% |
| Weighted Average Cost of Capital (WACC) | 6.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.02M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.87% in the last 52 weeks. The beta is 0.33, so ENVB's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -67.87% |
| 50-Day Moving Average | 2.36 |
| 200-Day Moving Average | 6.76 |
| Relative Strength Index (RSI) | 80.95 |
| Average Volume (20 Days) | 11,429,959 |
Short Selling Information
The latest short interest is 63,023, so 3.17% of the outstanding shares have been sold short.
| Short Interest | 63,023 |
| Short Previous Month | 70,703 |
| Short % of Shares Out | 3.17% |
| Short % of Float | 3.24% |
| Short Ratio (days to cover) | 2.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.77M |
| Pretax Income | -8.77M |
| Net Income | -12.13M |
| EBITDA | -8.57M |
| EBIT | -8.77M |
| Earnings Per Share (EPS) | -$36.24 |
Full Income StatementBalance Sheet
The company has $4.68 million in cash and n/a in debt, giving a net cash position of $4.68 million or $2.36 per share.
| Cash & Cash Equivalents | 4.68M |
| Total Debt | n/a |
| Net Cash | 4.68M |
| Net Cash Per Share | $2.36 |
| Equity (Book Value) | 4.18M |
| Book Value Per Share | 3.94 |
| Working Capital | 4.02M |
Full Balance SheetCash Flow
| Operating Cash Flow | -8.14M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 200,858 |
| Net Borrowing | n/a |
| Free Cash Flow | -8.14M |
| FCF Per Share | -$4.10 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |